版本:
中国

BRIEF-Asterias Biotherapeutics reports positive interim data from spinal cord injury treatment study

Sept 15 BioTime Inc

* BioTime affiliate, Asterias Biotherapeutics, announced positive interim efficacy data from trial in patients with complete cervical spinal cord injuries Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐